Inventor · disambiguated record
Calvin Theodore Broman
Also filed as: BROMAN CALVIN THEODORE
1 granted patent·9 pending applications·3 citations·filing 2015–2024
28Inventor score
Top patents by PatentIndex Score
10 records- 0181US10028916B2Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and useVIVUS INC·Filed 2015·Granted Jul 24, 2018·3 cites·13 claims
- 0275US2024382426A1Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and useVIVUS LLC·Filed 2024·Application pending·0 cites
- 0373US2024252523A1Orally administrable formulations for the controlled release of a pharmacologically active agentVIVUS LLC·Filed 2024·Application pending·0 cites
- 0467US2020030239A1Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and useVIVUS INC·Filed 2019·Application pending·0 cites
- 0566US2022226359A1Orally administrable formulations for the controlled release of a pharmacologically active agentVIVUS LLC·Filed 2022·Application pending·0 cites
- 0663US2019209595A1Orally administrable formulations for the controlled release of a pharmacologically active agentVIVUS INC·Filed 2018·Application pending·0 cites
- 0763US2021378964A1Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and useVIVUS LLC·Filed 2021·Application pending·0 cites
- 0862US2019133955A1Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and useVIVUS INC·Filed 2018·Application pending·0 cites
- 0961US2020215091A1Orally administrable formulations for the controlled release of a pharmacologically active agentVIVUS INC·Filed 2020·Application pending·0 cites
- 1053US2015328246A1Orally administratable formulations for the controlled release of a pharmacologically active agentVIVUS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Calvin Theodore Broman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →